Cargando…
Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial
BACKGROUND: Aspiration sclerotherapy is an effective therapeutic option for large symptomatic hepatic cysts. However, incomplete cyst reduction following aspiration sclerotherapy is frequently reported. Strong post-procedural cyst fluid secretion by cholangiocytes, which line the epithelium of the h...
Autores principales: | Wijnands, Titus FM, Gevers, Tom JG, Kool, Leo J Schultze, Drenth, Joost PH |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355152/ https://www.ncbi.nlm.nih.gov/pubmed/25873132 http://dx.doi.org/10.1186/s13063-015-0607-3 |
Ejemplares similares
-
Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial
por: Wijnands, Titus F. M., et al.
Publicado: (2018) -
Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts
por: Wijnands, Titus FM, et al.
Publicado: (2018) -
Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts
por: Neijenhuis, Myrte K., et al.
Publicado: (2018) -
Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient data
por: Wijnands, Titus F. M., et al.
Publicado: (2016) -
Aspiration–sclerotherapy Results in Effective Control of Liver Volume in Patients with Liver Cysts
por: van Keimpema, Loes, et al.
Publicado: (2008)